Schedule of Revenue Disaggregated by Type of Customer |
The following table summarizes the Company’s disaggregated revenue by payor category: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | 2025 | | 2024 | | GeneDx | | Other1 | | Total | | GeneDx | | Other1 | | Total | Diagnostic test revenue: | | | | | | | | | | | | Patients with third-party insurance | $ | 81,104 | | | $ | — | | | $ | 81,104 | | | $ | 50,462 | | | $ | 1,590 | | | $ | 52,052 | | Institutional customers | 18,380 | | | — | | | 18,380 | | | 16,695 | | | — | | | 16,695 | | Self-pay patients | 339 | | | — | | | 339 | | | 692 | | | — | | | 692 | | Total diagnostic test revenue | 99,823 | | | — | | | 99,823 | | | 67,849 | | | 1,590 | | | 69,439 | | Other revenue | 1,961 | | | 908 | | | 2,869 | | | 1,075 | | | — | | | 1,075 | | Total | $ | 101,784 | | | $ | 908 | | | $ | 102,692 | | | $ | 68,924 | | | $ | 1,590 | | | $ | 70,514 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six months ended June 30, | | 2025 | | 2024 | | GeneDx | | Other1 | | Total | | GeneDx | | Other1 | | Total | Diagnostic test revenue: | | | | | | | | | | | | Patients with third-party insurance | $ | 149,163 | | | $ | — | | | $ | 149,163 | | | $ | 93,340 | | | $ | 2,551 | | | $ | 95,891 | | Institutional customers | 35,984 | | | — | | | 35,984 | | | 33,369 | | | — | | | 33,369 | | Self-pay patients | 435 | | | — | | | 435 | | | 1,283 | | | — | | | 1,283 | | Total diagnostic test revenue | 185,582 | | | — | | | 185,582 | | | 127,992 | | | 2,551 | | | 130,543 | | Other revenue | 3,317 | | | 908 | | | 4,225 | | | 2,393 | | | — | | | 2,393 | | Total | $ | 188,899 | | | $ | 908 | | | $ | 189,807 | | | $ | 130,385 | | | $ | 2,551 | | | $ | 132,936 | |
(1)For the three and six months ended June 30, 2024, Other represents revenues associated with the Legacy Sema4 operating segment. For the three and six months ended June 30, 2025, revenues of the Fabric Genomics and Legacy Sema4 operating segments. See Note 15, “Segment Reporting” for more information.
|